Abstract
To study the CD26 density on monocytes and CD4+ T-lymphocytes in steroid and DMARD-naïve, early rheumatoid arthritis (RA) patients and to analyse for correlations with disease activity, including long-term radiographic progression.
| Original language | English |
|---|---|
| Journal | Clinical and Experimental Rheumatology |
| Volume | 30 |
| Issue number | 1 |
| Pages (from-to) | 58-63 |
| Number of pages | 6 |
| ISSN | 0392-856X |
| Publication status | Published - 2012 |
Keywords
- Adult
- Aged
- Antirheumatic Agents
- Arthritis, Rheumatoid
- CD4-Positive T-Lymphocytes
- Cyclosporine
- Dipeptidyl Peptidase 4
- Disease Progression
- Drug Therapy, Combination
- Female
- Humans
- Male
- Methotrexate
- Middle Aged
- Monocytes
- Treatment Outcome
Fingerprint
Dive into the research topics of 'Up-regulated dipeptidyl-peptidase IV (CD26) on monocytes was unaffected by effective DMARD treatment in early steroid and DMARD-naive rheumatoid arthritis'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS